NEW YORK, July 23 (GenomeWeb News) - Combimatrix will receive $2.3 million from a US Defense Department spending bill that was slated to be passed by Congress this week, the company said yesterday.
The funding is for the company's development of a microarray-based biosensor system to monitor biological and chemical agents that could pose threats. The system is being developed both for testing in the field of combat as well as within the US.
Combimatrix was originally awarded a $5.9 million contract in March by the Defense Department to develop this system. This new, additin funding is for continued development of the system.